Research demonstrates Hoth Therapeutics HT-KIT for mast cell cancers reduces size and spread
Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasm
Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasm
This work has been published in the journal ‘ACS applied materials and interface’
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
Startup receives US $ 5 million in first round of funding
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
The companies anticipate clinical studies to begin in August, subject to regulatory approvals
The expanded laboratories and manufacturing facilities at Nansha are expected to come online between Q1 2022 and Q3 2022
Has signed a 12-year, off-site, virtual power purchase agreement (VPPA) with Enel Green Power
PEL will explore the PLI scheme and apply if its beneficial.
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
Subscribe To Our Newsletter & Stay Updated